The primary cells global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Primary Cells Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The primary cells market size has grown rapidly in recent years. It will grow from $1.33 billion in 2023 to $1.49 billion in 2024 at a compound annual growth rate (CAGR) of 12.2%. The growth in the historic period can be attributed to rising prevalence of cancer, increasing investments in regenerative medicine research, growing demand for monoclonal antibodies, advantages of primary human cells over cell lines, increasing prevalence of chronic diseases.
The primary cells market size is expected to see rapid growth in the next few years. It will grow to $2.24 billion in 2028 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, growing focus on stem cell research, rising investments, increasing adoption of cell-based assays. Major trends in the forecast period include demand for human primary cells, advancements in research tools and technologies, adoption of cell-based therapies.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/primary-cells-global-market-report
Scope Of Primary Cells Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Primary Cells Market Overview
Market Drivers –
The rising government funding for cancer research is expected to propel the growth of the primary cells market going forward. Funding refers to the financial support provided to a project, initiative, organization, or individual to enable its development, operation, or achievement of specific goals. Government funding is used in primary cells to support research projects, personnel support, equipment and infrastructure, training and education, regulatory compliance, and technology development. For instance, in May 2022, the American Institute for Cancer Research (AICR), a US-based large American cancer research organization, requested $49 billion funding in 2023, which is an increase of $4.1 billion compared to the previous year’s $46.4 billion. Therefore, rising government funding for cancer research is expected to propel the growth of the primary cell market.
Market Trends –
Major companies operating in the primary cell market are focusing on advancements in cell products, such as a novel serum-free medium, to address the challenges faced by cell therapy developers in the manufacturing workflow, particularly for allogeneic cell therapy workflows. A novel serum-free medium is a culture or growth medium used in cell culture or tissue culture that does not contain serum, specifically fetal bovine serum (FBS) or other animal-derived sera. For instance, in January 2021, Thermo Fisher Scientific Inc., a US-based biotechnology company, launched Gibco CTS OpTmizer Pro Serum Free Medium (SFM) for the growth and expansion of human T lymphocytes, such as CD4+, CD8+, polyclonal, or antigen-specific T cells used in allogeneic cell therapies. This medium is designed to improve central memory phenotype and cell growth, leading to increased production of central memory cells in a shorter period. It is also suited for more extended workflows, supports high-density cultures, and is compatible with closed systems and automation.
The aerospace support and auxiliary equipment market covered in this report is segmented –
1) By Type: Commercial Radars, Satellites
2) By Ownership: Public, Private
3) By Platform: Airborne, Land, Naval, Space
Subsegments Covered: Continuous Waveform, Pulse Waveform, Large Satellite, Mini Satellite, Micro Satellite, Nano Satellite
Get an inside scoop of the primary cells market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=14165&type=smp
Regional Insights –
North America was the largest region in the primary cells market in 2023. The regions covered in the primary cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Major companies operating in the primary cells market are Thermo Fisher Scientific Inc, Merck KGaA , BD Biosciences, Corning Incorporated, Cytiva, Lonza Group Ltd, Charles River Laboratories Inc., STEMCELL Technologies Inc, American Type Culture Collection , Cell Signaling Technology, BioIVT, InvivoGen, HemaCare Corporation, Creative Bioarray Inc., PromoCell GmbH, CellGenix, AllCells LLC, Axol Bioscience Ltd, PBS Biotech Inc, AnaBios Corporation, ReachBio Research Labs, PELOBIOTECH GmbH, Cell Biologics Inc., ZenBio Inc., StemBioSys Inc
Table of Contents
1. Executive Summary
2. Primary Cells Market Report Structure
3. Primary Cells Market Trends And Strategies
4. Primary Cells Market – Macro Economic Scenario
5.Global Primary Cells Market Size And Growth
.
.
.
32. Global Primary Cells Market Competitive Benchmarking
33. Global Primary Cells Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Primary Cells Market
35. Primary Cells Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
